Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New analgesic agents disclosed in recent patent literature

Aug. 27, 2008

Novel Rac1/Rac1b inhibitors prevent Abeta production, display improved metabolic stability

Aug. 27, 2008

NP-12 reduces tau and beta-amyloid pathology in mice

Aug. 27, 2008

TRPM8 antagonism may attenuate hypersensitivity to cold

Aug. 27, 2008

NeuroDiscovery reports results from phase IIa clinical trials of NSL-101 in dental surgery

Aug. 26, 2008

Biovail gains Canadian approval for Ralivia for moderately severe pain

Aug. 26, 2008

Recent Mitsubishi Tanabe patent discloses new anxiolytic compounds

Aug. 26, 2008

Glycine transporter inhibitors identified at Merck for the treatment of schizophrenia

Aug. 26, 2008

RGH-478 reduces pain in arthritis models

Aug. 26, 2008

Subtype-selective GABA-A receptor modulator reduces neuropathic hypersensitivity in vivo

Aug. 26, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...